Smruthi Organics Limited (BOM:540686)
116.85
+1.75 (1.52%)
At close: Jan 22, 2026
Smruthi Organics Revenue
Smruthi Organics had revenue of 315.95M INR in the quarter ending September 30, 2025, with 7.50% growth. This brings the company's revenue in the last twelve months to 1.20B, up 0.11% year-over-year. In the fiscal year ending March 31, 2025, Smruthi Organics had annual revenue of 1.26B, down -1.28%.
Revenue (ttm)
1.20B
Revenue Growth
+0.11%
P/S Ratio
1.15
Revenue / Employee
4.49M
Employees
267
Market Cap
1.38B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.26B | -16.35M | -1.28% |
| Mar 31, 2024 | 1.28B | -133.98M | -9.50% |
| Mar 31, 2023 | 1.41B | 76.70M | 5.75% |
| Mar 31, 2022 | 1.33B | 68.71M | 5.43% |
| Mar 31, 2021 | 1.27B | -45.73M | -3.49% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Aarey Drugs & Pharmaceuticals | 4.28B |
| Infinium Pharmachem | 1.57B |
| Kimia Biosciences | 1.26B |
| Influx Healthtech | 1.24B |
| Panchsheel Organics | 1.03B |
| Resonance Specialties | 852.48M |
| Tyche Industries | 570.25M |
| Vasundhara Rasayans | 329.60M |